METHOD OF INTEGRATED infusion therapy in patients with diabetic coma hyperglycemic ketoatsidoticheskaya

摘要

1.method of integrated infusions for patients with u0433u0438u043fu0435u0440u0433u043bu0438u043au0435u043cu0438u0447u0435u0441u043au043eu0439 u043au0435u0442u043eu0430u0446u0438u0434u043eu0442u0438u0447u0435u0441u043au043eu0439 diabetic with veronika, including the introduction of a consistent u0441u0435u0431u00a0 u0432u0430u0442u0435u043bu044cu043du043eu0441u0442u0438 salt and u0431u0435u0441u0441u043eu043bu0435u0432u044bu0445 solutions and u043au043eu043bu043bu043eu0438u0434u043du044bu0445 solutions in a given amount, the ratio of which are dependent on u0442u00a0u0436u0435u0441u0442u0438 u0441u043eu0441u0442u043eu00a0u043du0438u00a0 ball u044cu043du043eu0433u043e,estimated scale SAPS with introduction of infusion solutions u043eu0441u0443u0449u0435u0441u0442u0432u043bu00a0u044eu0442 alternately, a salt solutions using u043au0440u0438u0441u0442u0430u043bu043bu043eu0438u0434u044b (saline and / or ringer's solution), with the addition of 10% saline solution control valve and 1.5% u0440u0435u0430u043cu0431u0438u0440u0438u043du0430, as u0431u0435u0441u0441u043eu043bu0435u0432u043eu0433u043e solution used 5% glucose.as well as u043au043eu043bu043bu043eu0438u0434u043du044bu0445 solutions using 6% solution of u0433u0438u0434u0440u043eu043au0441u0438u044du0442u0438u043b - starch and 10% solution of albumin, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, further u043eu0441u0443u0449u0435u0441u0442u0432u043bu00a0u044eu0442 u043fu043eu0441u043bu0435u0434u043eu0432u0430u0442 u0435u043bu044cu043du043eu0435 injecting u0430u043du0442u0438u0433u0438u043fu043eu043au0441u0430u043du0442u043eu0432 (u0440u0435u0430u043cu0431u0438u0440u0438u043d), u043fu0440u043eu043eu043au0441u0438u0434u0430u043du0442u043eu0432 (u043eu0437u043eu043du0438u0440u043eu0432u0430u043du043du044bu0439 saline) and antioxidants (u0446u0438u0442u043eu0444u043bu0430u0432u0438u043d, u043cu0435u043au0441u0438u0434u043eu043b, u043bu0438u043fu043eu0435u0432u0430 u00a0 acid) in the first degree u0442u00a0u0436u0435u0441u0442u0438 u0432u0432u043eu0434u00a0u0442 solution u0440u0435u0430u043cu0431u0438u0440u0438u043du0430 15% of daily dose of 6 ml / kg, the dose of the active substance (ozone) u0441u043eu0441u0442u0430u0432u043bu00a0u0435u0442 20 mg / kg dose u043cu0435u043au0441u0438u0434u043eu043bu0430 3 mg / kg; in the second part u0442u00a0u0436u0435u0441u0442u0438 u0432u0432u043eu0434u00a0u0442 solution u0440u0435u0430u043cu0431u0438u0440u0438u043du0430 1.5% in soot u0447u043du043eu0439 dose 12 ml / kg, u0441u043eu0441u0442u0430u0432u043bu00a0u0435u0442 ozone dose and the dose of 20 mg / kg u043cu0435u043au0441u0438u0434u043eu043bu0430 5 mg / kg; in the third part u0442u00a0u0436u0435u0441u0442u0438 u0432u0432u043eu0434u00a0u0442 solution u0440u0435u0430u043cu0431u0438u0440u0438u043du0430 15% of daily dose of 12 ml / kg with the transition after 6 h on supportive therapy u0446u0438u0442u043eu0444u043bu0430u0432u0438u043du043eu043c in daily dose of 0.3 ml / kg, the dose of ozone u0441u043eu0441u0442u0430u0432u043bu00a0u0435u0442 30 to 35 mg / kg dose of 10 mg / u043cu0435u043au0441u0438u0434u043eu043bu0430 kg, except that in 3 h after u0432u0432u0435u0434u0435u043du0438u00a0 u043eu0437u043eu043du0438u0440u043eu0432u0430u043du043du043eu0433u043e physiological saline u0432u0432u043eu0434u00a0u0442 - u043bu0438u043fu043eu0435u0432u0443u044e acid in a dose of 4 iu / kg intravenously within an hour; in the fourth the degree of u0442u00a0u0436u0435u0441u0442u0438 solution u0440u0435u0430u043cu0431u0438u0440u0438u043du0430 15% of daily dose of 6 ml / kg of transition in 6 h in supportive therapy u0446u0438u0442u043eu0444u043bu0430u0432u0438u043du043eu043c in daily dose of 0.5 ml / kg, the dose of ozone u0441u043eu0441u0442u0430u0432u043bu00a0u0435u0442 15 mg / kg, and 10 mg / kg dose u043cu0435u043au0441u0438u0434u043eu043bu0430 besides this in 3 h after u0432u0432u0435u0434u0435u043du0438u00a0 u043eu0437u043eu043du0438u0440u043eu0432u0430u043du043du043eu0433u043e physiological saline u0432u0432u043eu0434u00a0u0442 - u043bu0438u043fu043eu0435u0432u0443u044e acid in a dose of 8 iu / kg intravenously within an hour.;2. method for u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 1, so that the u043cu0435u043au0441u0438u0434u043eu043b set at intervals of u0432u0432u0435u0434u0435u043du0438u00a0 1 and 12 hours.